Business Wire

Burger King Worldwide Holdings, Inc. Announces Aggressive Expansion Plans for BURGER KING® Brand in Russia

Share
FL-BURGER-KING/VTB

Several Hundred BURGER KING ®  Restaurants To Open Over Next Few Years As Part of New Joint Venture with Burger Rus and VTB Capital

Burger King Worldwide Holdings, Inc. (“BKW”) today announced the establishment of a new joint venture in Russia focused on aggressively expanding the BURGER KING®  brand presence in this high-growth emerging market. Under the new partnership, BKW, Burger Rus, the largest BURGER KING®  franchisee in Russia, and VTB Capital, a leading Russian investment bank, are committed to opening several hundred BURGER KING®  restaurants over the next few years.

“We are thrilled to announce this joint venture,” said José Cil , president, EMEA, BKW. “We believe there is tremendous opportunity to rapidly increase our market share in Russia's fast-growing and underpenetrated quick-service restaurant (QSR) sector. Today’s announcement is a great example of our company’s strategy to accelerate international expansion by creating master franchisee agreements with strong local partners in high-growth markets.”

Burger Rus already has a strong presence in Russia, having opened 54 BURGER KING® restaurants in the country in the last 30 months. “Alex Kolobov and the leadership team at Burger Rus have an excellent track record,” Cil  continued. “We look forward to significantly expanding the scope of our partnership, while simultaneously introducing the iconic BURGER KING®  brand to millions of new consumers in Russia.”

The newly formed Russian joint venture uniquely positions the BURGER KING®  brand for rapid expansion by combining significant financial resources with industry-leading operational know-how. Under the terms of the partnership, the new venture has signed a long-term master franchise and development agreement with BKW, and has obtained the exclusive rights to expand the BURGER KING®  brand in Russia.

“The growth potential of the Russian QSR market is tremendous as we have witnessed by the success of the 54 BURGER KING®  restaurants that we already operate in the country,” said Alexander Kolobov , managing shareholder, Burger Rus. "The strength of the BURGER KING®  brand and its world-famous menu items, such as the iconic WHOPPER®  sandwich, are key drivers for further growth in this market.”

Tim Demchenko , Head of Private Equity and Special Situations at VTB Capital, said: "This deal is yet another milestone in growing VTB Capital’s private equity business, and another example of VTB Capital successfully forming international partnerships to develop attractive market opportunities in Russia and CIS. We plan to continue entering into partnerships with top-tier international companies to take advantage of the strong underlying consumer demand and underpenetrated market in Russia."

The partnership with Burger Rus and VTB Capital is the latest example of BKW’s commitment to deliver on its aggressive international growth strategy in key developing markets. In 2011, BKW successfully introduced a similar joint venture in Brazil focused on increasing market share in one of South America’s fastest-growing economies.

Burger Rus was advised in the transaction by Olympia Capital, which also retained a minority stake in Burger Rus within the framework of the joint venture.

Forward-Looking Statements

This press release includes forward-looking statements, which are often identified by the words “may,” “might,” “believes,” “thinks,” “anticipates,” “plans,” “expects”, “intends” or similar expressions, and include statements regarding BKW’s expectations regarding the growth opportunities in Russia and the ability of the joint venture to capitalize on these opportunities and rapidly expand the BURGER KING® brand’s presence in Russia. These forward-looking statements may be affected by risks and uncertainties in BKW’s business and market conditions. This information is qualified in its entirety by cautionary statements and risk factor disclosure contained in filings made by Burger King Holdings, Inc. (“Holdings”) with the Securities and Exchange Commission, including Holdings’ report on Form 10-K for the year ended December 31 2011. BKW wishes to caution readers that certain important factors may have affected and could in the future affect BKW’s actual results and could cause BKW’s actual results for subsequent periods to differ materially from those expressed in any forward-looking statement made by or on behalf of BKW, including the risk that the joint venture will not be successful in opening BURGER KING® restaurants in Russia or that the opportunities to open restaurants in Russia will decline. BKW undertakes no obligation to update forward-looking statements to reflect events or circumstances after the date hereof.

ABOUT BURGER KING WORLDWIDE HOLDINGS, INC.

Founded in 1954, BURGER KING® is the second largest fast food hamburger chain in the world. The original HOME OF THE WHOPPER® , the BURGER KING® system operates in over 12,500 locations serving more than 11 million guests daily in 82 countries and territories worldwide. Approximately 90 percent of BURGER KING® restaurants are owned and operated by independent franchisees, many of them family-owned operations that have been in business for decades. Burger King Worldwide Holdings, Inc. is privately-held by 3G Capital, a multi-billion dollar, global investment firm focused on long-term value creation. For more information on 3G Capital, please go to http://3g-capital.com . To learn more about Burger King Worldwide Holdings, Inc., please visit the company's website at www.bk.com or follow us on Facebook and Twitter.

ABOUT VTB CAPITAL

VTB Capital, the Investment Business of VTB Group, is one of the three strategic business arms of VTB Group, along with the corporate and retail businesses. Since its foundation in 2008, VTB Capital has taken part in more than 276 ECM and DCM deals, which were instrumental in attracting more than USD 113.2bn worth of investments to Russia and CIS. VTB Capital offers a full range of investment banking products and services to Russian and international clients, focusing on arranging operations in the debt, equity, global commodities markets, developing investment and asset management, advising clients on M&A and ECM deals in Russia and abroad. VTB Capital operates in Moscow, London, Singapore, Dubai, Hong Kong, Sofia, New York, Paris and Vienna, with headquarters in Moscow. VTB Capital holds top positions in the debt and equity capital markets in Russia and CIS according to the league tables for 2011 by Dealogic and Bloomberg. In 2011 VTB Capital research team was ranked No. 1 in Thomson Reuters Extel Survey and Institutional Investor All-Russia Investor Survey.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50301279&lang=en

Contact:

For Burger King Worldwide Holdings, Inc.
Miguel Piedra, +1 305-378-7277
Vice President, Global Communications
mpiedra@whopper.com
or
Kati Kaskeala, +34 630 77 34 81
Director, Communications and Public Affairs, EMEA
kkaskeala@whopper.com
or
For VTB Capital
Julia Govorun, +7 916 026 85 79
Senior Press officer
Julia.Govorun@vtbcapital.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release

Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi

IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release

IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release

Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s

NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release

NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates

Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release

As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye